ARE THE FACTORS AFFECTING ADVERSE PREGNANCY OUTCOMES DIFFERENT IN OBESE GESTATIONAL DIABETES PREGNANT WOMEN RECEIVING DIET OR INSULIN TREATMENT?

adverse pregnancy outcomes diet therapy insulin therapy obese gestational diabetes weight gain during pregnancy

Journal

Acta endocrinologica (Bucharest, Romania : 2005)
ISSN: 1841-0987
Titre abrégé: Acta Endocrinol (Buchar)
Pays: Romania
ID NLM: 101269720

Informations de publication

Date de publication:
Historique:
entrez: 8 5 2020
pubmed: 8 5 2020
medline: 8 5 2020
Statut: ppublish

Résumé

We aimed to examine the factors affecting adverse gestational outcome in gestational diabetes (GDM) patients, who were grouped as obese and normal- weight, having only-diet, or insulin treatments. The study included 373 patients, treated with diet or insulin. These patients were sub-grouped as obese and non-obese, and examined retrospectively. The variables affecting adverse gestational outcome in obese GDM patients having dietary and/ or insulin treatments were detected with multiple regression analysis. The weight gained during pregnancy in the GDM group having insulin treatment was more than the one in only-diet treated GDM group (p=0.004). Pre-pregnancy body mass index, the weight gained during pregnancy, hemoglobin A1C levels in the second and third trimesters, caesarian rates were higher in the insulin-treated obese patients than in the other groups (p<0.001). The odds ratio for fasting blood glucose level in insulin-treated obese GDM group was 1.081 (95% CI =1.004 - 1.163) (p=0.039); and it was 0.982 (95% CI =0.924 - 1.002) (p=0.048) for the weight gained during pregnancy, in only-diet treated obese GDM patients. The control of weight gained during pregnancy, and of fasting blood glucose levels in obese patients having GDM, is important to decrease adverse gestational outcome.

Identifiants

pubmed: 32377245
doi: 10.4183/aeb.2019.472
pii: aeb.2019.472
pmc: PMC7200116
doi:

Types de publication

Journal Article

Langues

eng

Pagination

472-481

Informations de copyright

©by Acta Endocrinologica Foundation.

Déclaration de conflit d'intérêts

None of the authors received any financial support that could be considered a potential conflict of interest regarding the manuscript or its submissionInformed consent was obtained from all patients for being included in the study.

Références

Am J Public Health. 2010 Jun;100(6):1047-52
pubmed: 20395581
Sci Rep. 2017 Mar 22;7(1):305
pubmed: 28331199
Health Technol Assess. 2012 Jul;16(31):iii-iv, 1-191
pubmed: 22814301
Acta Diabetol. 2015 Jun;52(3):445-52
pubmed: 25344768
Gynecol Endocrinol. 2016;32(5):416-20
pubmed: 27052494
Dan Med J. 2014 Jul;61(7):B4893
pubmed: 25123127
Diabetes Educ. 1991 Nov-Dec;17(6):455-9
pubmed: 1935552
Obes Rev. 2009 Mar;10(2):194-203
pubmed: 19055539
Cell Stress Chaperones. 2016 May;21(3):515-22
pubmed: 26902078
Przegl Lek. 2005;62(1):38-41
pubmed: 16053219
Obstet Gynecol. 2013 Aug;122(2 Pt 1):406-16
pubmed: 23969827
Diabetes Care. 2010 Jan;33 Suppl 1:S62-9
pubmed: 20042775
Pediatrics. 2005 Mar;115(3):e290-6
pubmed: 15741354
PLoS One. 2017 Jun 2;12(6):e0177418
pubmed: 28575041
Matern Child Health J. 2014 Oct;18(8):1919-26
pubmed: 24531925
Lancet. 2006 Sep 30;368(9542):1164-70
pubmed: 17011943
Diabetes Metab. 2016 Feb;42(1):38-46
pubmed: 26141553
Acta Endocrinol (Buchar). 2018 Apr-Jun;14(2):213-218
pubmed: 31149260
J Clin Endocrinol Metab. 2013 Nov;98(11):4227-49
pubmed: 24194617

Auteurs

S Özler (S)

Selçuk University - Perinatology, Turkey.

E Oztas (E)

Eskişehir, Istanbul, Turkey.

B G Guler (BG)

Istinye University, Istanbul, Turkey.

M Alci (M)

Selçuk University - Konya, Turkey.

A T Caglar (AT)

Acibadem University, Ankara, Turkey.

N Danişman (N)

Acibadem University, Istanbul, Turkey.

Classifications MeSH